| Identification of a human heme exporter that is essential for erythropoiesis JG Quigley, Z Yang, MT Worthington, JD Phillips, KM Sabo, DE Sabath, ... Cell 118 (6), 757-766, 2004 | 491 | 2004 |
| A heme export protein is required for red blood cell differentiation and iron homeostasis SB Keel, RT Doty, Z Yang, JG Quigley, J Chen, S Knoblaugh, PD Kingsley, ... Science 319 (5864), 825-828, 2008 | 464 | 2008 |
| Development of a definition of postacute sequelae of SARS-CoV-2 infection T Thaweethai, SE Jolley, EW Karlson, EB Levitan, B Levy, GA McComsey, ... Jama 329 (22), 1934-1946, 2023 | 248 | 2023 |
| Control of intracellular heme levels: heme transporters and heme oxygenases AA Khan, JG Quigley Biochimica Et Biophysica Acta (BBA)-Molecular Cell Research 1813 (5), 668-682, 2011 | 242 | 2011 |
| Cloning of the cellular receptor for feline leukemia virus subgroup C (FeLV-C), a retrovirus that induces red cell aplasia JG Quigley, CC Burns, MM Anderson, ED Lynch, KM Sabo, J Overbaugh, ... Blood, The Journal of the American Society of Hematology 95 (3), 1093-1099, 2000 | 173 | 2000 |
| Nonmyeloablative stem cell transplantation with alemtuzumab/low-dose irradiation to cure and improve the quality of life of adults with sickle cell disease SL Saraf, AL Oh, PR Patel, Y Jalundhwala, K Sweiss, M Koshy, ... Biology of Blood and Marrow Transplantation 22 (3), 441-448, 2016 | 136 | 2016 |
| Heme and FLVCR-related transporter families SLC48 and SLC49 AA Khan, JG Quigley Molecular aspects of medicine 34 (2-3), 669-682, 2013 | 119 | 2013 |
| Effect of P2Y12 inhibitors on survival free of organ support among non–critically ill hospitalized patients with COVID-19: a randomized clinical trial JS Berger, LZ Kornblith, MN Gong, HR Reynolds, M Cushman, Y Cheng, ... Jama 327 (3), 227-236, 2022 | 102 | 2022 |
| The transcription factor Foxm1 is essential for the quiescence and maintenance of hematopoietic stem cells Y Hou, W Li, Y Sheng, L Li, Y Huang, Z Zhang, T Zhu, D Peace, ... Nature immunology 16 (8), 810-818, 2015 | 77 | 2015 |
| Haploidentical peripheral blood stem cell transplantation demonstrates stable engraftment in adults with sickle cell disease SL Saraf, AL Oh, PR Patel, K Sweiss, M Koshy, S Campbell-Lee, ... Biology of Blood and Marrow Transplantation 24 (8), 1759-1765, 2018 | 56 | 2018 |
| Differential effects of epigenetic modifiers on the expansion and maintenance of human cord blood stem/progenitor cells N Mahmud, B Petro, S Baluchamy, X Li, S Taioli, D Lavelle, JG Quigley, ... Biology of Blood and Marrow Transplantation 20 (4), 480-489, 2014 | 55 | 2014 |
| Combination of linear accelerator–based intensity-modulated total marrow irradiation and myeloablative fludarabine/busulfan: A phase I study P Patel, B Aydogan, M Koshy, D Mahmud, A Oh, SL Saraf, JG Quigley, ... Biology of Blood and Marrow Transplantation 20 (12), 2034-2041, 2014 | 47 | 2014 |
| Structural racism is a mediator of disparities in acute myeloid leukemia outcomes IE Abraham, GH Rauscher, AA Patel, WB Pearse, P Rajakumar, M Burkart, ... Blood, The Journal of the American Society of Hematology 139 (14), 2212-2226, 2022 | 44 | 2022 |
| Fludarabine/iv BU conditioning regimen: myeloablative, reduced intensity or both? S Chunduri, LC Dobogai, D Peace, Y Saunthararajah, J Quigley, ... Bone marrow transplantation 41 (11), 935-940, 2008 | 41 | 2008 |
| A treatment algorithm to identify therapeutic approaches for leg ulcers in patients with sickle cell disease IA Altman, RE Kleinfelder, JG Quigley, WJ Ennis, CP Minniti International Wound Journal 13 (6), 1315-1324, 2016 | 38 | 2016 |
| Heterogeneous treatment effects of therapeutic-dose heparin in patients hospitalized for COVID-19 EC Goligher, PR Lawler, TP Jensen, V Talisa, LR Berry, E Lorenzi, ... Jama 329 (13), 1066-1077, 2023 | 33 | 2023 |
| The birth, life, and death of red blood cells: erythropoiesis, the mature red blood cell, and cell destruction JG Quigley, RT Means, B Glader Wintrobe’s clinical hematology, 83-124, 2014 | 33 | 2014 |
| Reliability of a pretransplant iv BU test dose performed 2 weeks before myeloablative FluBu conditioning regimen R Beri, S Chunduri, K Sweiss, DJ Peace, C Mactal-Haaf, LC Dobogai, ... Bone marrow transplantation 45 (2), 249-253, 2010 | 31 | 2010 |
| Comparable kinetics of myeloablation between fludarabine/full-dose busulfan and fludarabine/melphalan conditioning regimens in allogeneic peripheral blood stem cell transplantation S Chunduri, LC Dobogai, D Peace, Y Saunthararajah, HY Chen, ... Bone marrow transplantation 38 (7), 477-482, 2006 | 28 | 2006 |
| Investigation of a putative role for FLVCR, a cytoplasmic heme exporter, in Diamond-Blackfan anemia JG Quigley, H Gazda, Z Yang, S Ball, CA Sieff, JL Abkowitz Blood Cells, Molecules, and Diseases 35 (2), 189-192, 2005 | 28 | 2005 |
